期刊文献+

年龄相关性黄斑变性的治疗进展 被引量:8

Research progress in the treatment of age-related macular degeneration
下载PDF
导出
摘要 年龄相关性黄斑变性(Age-related macular degeneration,AMD)又称老年性黄斑变性,是发达国家视功能障碍和失明的主要原因,在发展中国家发病率有明显上升趋势。近年来,随着我国人民生活水平的提高,人口日益老龄化,该病发病率增加,成为眼科防盲研究的重要课题之一。目前相关学者对AMD治疗研究也取得了相当大的进展。本文就AMD治疗方法及其进展做一综述。 Age-related macular degeneration(AMD),also known as senile macular degeneration,is one of the leading causes of blindness in the developed countries,which showed increasing incidences in the developing countries.In recent years,with the improvement of living standards and an increasingly aging population,incidence of AMD in China has gradually increased.Currently the treatment of AMD-related academic research has also made considerable progress.In this paper,the progress in the treatment of AMD was reviewed.
作者 王小琴 谢青
出处 《海南医学》 CAS 2012年第10期127-130,共4页 Hainan Medical Journal
关键词 老年性黄斑变性 治疗 进展 Age-related macular degeneration Treatment Progress
  • 相关文献

参考文献33

  • 1Klein R,Klein BE,Linton KL.Prevalence of age-related maculopa-thy.The Beaver Dam Eye Study[J].Ophthalmology,1992,99(6):933-943.
  • 2Jermak CM,Dellacroce JT,Heffez J,et al.Triamcinolone acetonide in ocular therapeutics[J].Surv Ophthalmol,2007,52(5):503-522.
  • 3Penfold PL,Gyory J,Hunyor A,et al.Effects of triamcinolone ace-tonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration[J].Clin Ex-periment Ophthalmol,2001,29(3):188-192.
  • 4Jonas JB,Akkoyun I,Budde WM,et al.Exudative age-related macu-lar degeneration treated by intravitreal triamcinolone acetonide.A prospective comparative nonrandomized study[J].Eye(Lond),2005,19(2):163-170.
  • 5Christen WG,Glynn RJ,Chew EY,et al.Low-dose aspirin and medi-cal record-confirmed age-related macular degeneration in a random-ized trial of women[J].Ophthalmology,2009,116(12):2386-2392.
  • 6Yoshinaga N,Arimura N,Otsuka H,et al.NSAIDs inhibit neovascu-larization of choroid through HO-1-dependent pathway[J].Lab In-vest,2011,91(9):1277-1290.
  • 7Augustin A.Anecortave acetate in the treatment of age-related macu-lar degeneration[J].Clin Interv Aging,2006,1(3):237-246.
  • 8Aggermann T,Haas PS.Binder.Anecortave acetate for fibrotic le-sions with presence of residual peripheral activity in age-related macular degeneration[J].Ann Ophthalmol(Skokie),2008,40(1):28-30.
  • 9Grisanti S.Bevacizumab:off-label use in ophthalmology[J].Indian J Ophthalmol,2007,55(6):417-420.
  • 10Takahashi M,Kishi S.Intravitreal bevacizumab for age-related mac-ular degeneration with good visual acuity[J].Jpn J Ophthalmol,2010,54(6):565-570.

共引文献1

同被引文献104

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部